{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:43:30Z","timestamp":1793598210423,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-57382-9","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T10:04:18Z","timestamp":1741601058000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Impact of liver fibrosis on AAV-mediated gene transfer to mouse hepatocytes"],"prefix":"10.1038","volume":"16","author":[{"given":"Rosa","family":"Ferriero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9196-2384","authenticated-orcid":false,"given":"Gemma","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Padula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iolanda","family":"Boffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0645-9800","authenticated-orcid":false,"given":"Marco","family":"Gargaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Imperatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4519-8474","authenticated-orcid":false,"given":"Maria","family":"Battipaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Vivenzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Perna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Nusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6439-4326","authenticated-orcid":false,"given":"Adrian","family":"Westhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddison","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5697-2648","authenticated-orcid":false,"given":"Giorgia","family":"Manni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severo","family":"Campione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evaristo","family":"Di Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Polishchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7698-1955","authenticated-orcid":false,"given":"Roman","family":"Polishchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando","family":"Paciello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6895-8819","authenticated-orcid":false,"given":"Nicola","family":"Brunetti-Pierri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4772-8651","authenticated-orcid":false,"given":"Leszek","family":"Lisowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8501-2136","authenticated-orcid":false,"given":"Francesca","family":"Fallarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8614-2581","authenticated-orcid":false,"given":"Pasquale","family":"Piccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"57382_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S2468-1253(16)30205-9","volume":"2","author":"R Harris","year":"2017","unstructured":"Harris, R., Harman, D. J., Card, T. R., Aithal, G. P. & Guha, I. N. Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review. Lancet Gastroenterol. Hepatol. 2, 288\u2013297 (2017).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"57382_CR2","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/petr.12741","volume":"20","author":"K Oishi","year":"2016","unstructured":"Oishi, K., Arnon, R., Wasserstein, M. P. & Diaz, G. A. Liver transplantation for pediatric inherited metabolic disorders: considerations for indications, complications, and perioperative management. Pediatr. Transpl. 20, 756\u2013769 (2016).","journal-title":"Pediatr. Transpl."},{"key":"57382_CR3","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1002\/jimd.12144","volume":"42","author":"G Ranucci","year":"2019","unstructured":"Ranucci, G. et al. Chronic liver involvement in urea cycle disorders. J. Inherit. Metab. Dis. 42, 1118\u20131127 (2019).","journal-title":"J. Inherit. Metab. Dis."},{"key":"57382_CR4","doi-asserted-by":"crossref","unstructured":"Burrow, T. A., Bove, K. E. & Grabowski, G. A. The liver in lysosomal storage diseases. In Liver Disease in Children 3 edn (eds Suchy, F. J., Sokol, R. J. & Balistreri, W. F.) (Cambridge Univ. Press, 2007).","DOI":"10.1017\/CBO9780511547409.032"},{"key":"57382_CR5","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","volume":"365","author":"AC Nathwani","year":"2011","unstructured":"Nathwani, A. C. et al. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N. Engl. J. Med. 365, 2357\u20132365 (2011).","journal-title":"N. Engl. J. Med."},{"key":"57382_CR6","doi-asserted-by":"crossref","unstructured":"Piccolo, P., Rossi, A. & Brunetti-Pierri, N. Liver-directed gene-based therapies for inborn errors of metabolism. Expert Opin. Biol. Ther., 1\u201312 (2020).","DOI":"10.1080\/14712598.2020.1817375"},{"key":"57382_CR7","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s40265-022-01788-y","volume":"82","author":"HA Blair","year":"2022","unstructured":"Blair, H. A. Valoctocogene roxaparvovec: first approval. Drugs 82, 1505\u20131510 (2022).","journal-title":"Drugs"},{"key":"57382_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40265-023-01845-0","volume":"83","author":"YA Heo","year":"2023","unstructured":"Heo, Y. A. Etranacogene dezaparvovec: first approval. Drugs 83, 347\u2013352 (2023).","journal-title":"Drugs"},{"key":"57382_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s40265-024-02017-4","volume":"84","author":"S Dhillon","year":"2024","unstructured":"Dhillon, S. Fidanacogene elaparvovec: first approval. Drugs 84, 479\u2013486 (2024).","journal-title":"Drugs"},{"key":"57382_CR10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00535-016-1190-4","volume":"51","author":"T Greuter","year":"2016","unstructured":"Greuter, T. & Shah, V. H. Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights. J. Gastroenterol. 51, 511\u2013519 (2016).","journal-title":"J. Gastroenterol."},{"key":"57382_CR11","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1182\/blood-2016-11-751040","volume":"129","author":"GL Rogers","year":"2017","unstructured":"Rogers, G. L. et al. Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8(+) T cells. Blood 129, 3184\u20133195 (2017).","journal-title":"Blood"},{"key":"57382_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1089\/hum.2013.086","volume":"24","author":"R van Dijk","year":"2013","unstructured":"van Dijk, R. et al. Polyinosinic acid blocks adeno-associated virus macrophage endocytosis in vitro and enhances adeno-associated virus liver-directed gene therapy in vivo. Hum. Gene Ther. 24, 807\u2013813 (2013).","journal-title":"Hum. Gene Ther."},{"key":"57382_CR13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/cmi.2011.53","volume":"9","author":"R Xu","year":"2012","unstructured":"Xu, R., Zhang, Z. & Wang, F. S. Liver fibrosis: mechanisms of immune-mediated liver injury. Cell. Mol. Immunol. 9, 296\u2013301 (2012).","journal-title":"Cell. Mol. Immunol."},{"key":"57382_CR14","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1128\/JVI.75.15.6969-6976.2001","volume":"75","author":"H Nakai","year":"2001","unstructured":"Nakai, H. et al. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo. J. Virol. 75, 6969\u20136976 (2001).","journal-title":"J. Virol."},{"key":"57382_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/978-1-4939-6786-5_19","volume":"1559","author":"YO Kim","year":"2017","unstructured":"Kim, Y. O., Popov, Y. & Schuppan, D. Optimized mouse models for liver fibrosis. Methods Mol. Biol. 1559, 279\u2013296 (2017).","journal-title":"Methods Mol. Biol."},{"key":"57382_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2353\/ajpath.2006.050312","volume":"168","author":"D Huster","year":"2006","unstructured":"Huster, D. et al. Consequences of copper accumulation in the livers of the Atp7b-\/- (Wilson disease gene) knockout mice. Am. J. Pathol. 168, 423\u2013434 (2006).","journal-title":"Am. J. Pathol."},{"key":"57382_CR17","doi-asserted-by":"publisher","first-page":"5081","DOI":"10.1096\/fj.12-209379","volume":"26","author":"K Hochrath","year":"2012","unstructured":"Hochrath, K. et al. The hepatic phosphatidylcholine transporter ABCB4 as modulator of glucose homeostasis. FASEB J. 26, 5081\u20135091 (2012).","journal-title":"FASEB J."},{"key":"57382_CR18","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1182\/blood-2002-09-2889","volume":"102","author":"AM Davidoff","year":"2003","unstructured":"Davidoff, A. M., Ng, C. Y., Zhou, J., Spence, Y. & Nathwani, A. C. Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway. Blood 102, 480\u2013488 (2003).","journal-title":"Blood"},{"key":"57382_CR19","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1002\/hep.30773","volume":"70","author":"SM Siew","year":"2019","unstructured":"Siew, S. M. et al. Prevention of cholestatic liver disease and reduced tumorigenicity in a murine model of PFIC type 3 using hybrid AAV-piggyBac gene therapy. Hepatology 70, 2047\u20132061 (2019).","journal-title":"Hepatology"},{"key":"57382_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature16465","volume":"530","author":"S Pillay","year":"2016","unstructured":"Pillay, S. et al. An essential receptor for adeno-associated virus infection. Nature 530, 108\u2013112 (2016).","journal-title":"Nature"},{"key":"57382_CR21","doi-asserted-by":"publisher","first-page":"9831","DOI":"10.1128\/JVI.00878-06","volume":"80","author":"B Akache","year":"2006","unstructured":"Akache, B. et al. The 37\/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J. Virol. 80, 9831\u20139836 (2006).","journal-title":"J. Virol."},{"key":"57382_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nbt.1515","volume":"27","author":"KD Foust","year":"2009","unstructured":"Foust, K. D. et al. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat. Biotechnol. 27, 59\u201365 (2009).","journal-title":"Nat. Biotechnol."},{"key":"57382_CR23","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1089\/hum.2019.264","volume":"31","author":"A Westhaus","year":"2020","unstructured":"Westhaus, A. et al. High-throughput in vitro, ex vivo, and in vivo screen of adeno-associated virus vectors based on physical and functional transduction. Hum. Gene Ther. 31, 575\u2013589 (2020).","journal-title":"Hum. Gene Ther."},{"key":"57382_CR24","doi-asserted-by":"crossref","unstructured":"Piccolo, P. & Brunetti-Pierri, N. Current and Emerging Issues in Adeno-Associated Virus Vector-Mediated Liver-Directed Gene Therapy. Hum. Gene Ther. 36, 77\u201387 (2025).","DOI":"10.1089\/hum.2024.179"},{"key":"57382_CR25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/gt.2011.119","volume":"19","author":"L Sobrevals","year":"2012","unstructured":"Sobrevals, L. et al. AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers. Gene Ther. 19, 411\u2013417 (2012).","journal-title":"Gene Ther."},{"key":"57382_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.omtm.2020.10.023","volume":"20","author":"A Carestia","year":"2021","unstructured":"Carestia, A. et al. Modulation of the liver immune microenvironment by the adeno-associated virus serotype 8 gene therapy vector. Mol. Ther. Methods Clin. Dev. 20, 95\u2013108 (2021).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"57382_CR27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3389\/fimmu.2020.00670","volume":"11","author":"G Ronzitti","year":"2020","unstructured":"Ronzitti, G., Gross, D. A. & Mingozzi, F. Human immune responses to adeno-associated virus (AAV) vectors. Front. Immunol. 11, 670 (2020).","journal-title":"Front. Immunol."},{"key":"57382_CR28","doi-asserted-by":"crossref","unstructured":"Yu, D. L., Chow, N. S. M., Bridle, B. W. & Wootton, S. K. Macrophage depletion via clodronate pretreatment reduces transgene expression from AAV vectors in vivo. Viruses 13, 2002 (2021).","DOI":"10.3390\/v13102002"},{"key":"57382_CR29","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/hep.23043","volume":"50","author":"E Breous","year":"2009","unstructured":"Breous, E., Somanathan, S., Vandenberghe, L. H. & Wilson, J. M. Hepatic regulatory T cells and Kupffer cells are crucial mediators of systemic T cell tolerance to antigens targeting murine liver. Hepatology 50, 612\u2013621 (2009).","journal-title":"Hepatology"},{"key":"57382_CR30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1055\/s-0031-1286055","volume":"31","author":"M Johncilla","year":"2011","unstructured":"Johncilla, M. & Mitchell, K. A. Pathology of the liver in copper overload. Semin. Liver Dis. 31, 239\u2013244 (2011).","journal-title":"Semin. Liver Dis."},{"key":"57382_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0910-7","volume":"13","author":"J Bj\u00f6rklund","year":"2018","unstructured":"Bj\u00f6rklund, J. et al. High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study. Orphanet J. Rare Dis. 13, 169 (2018).","journal-title":"Orphanet J. Rare Dis."},{"key":"57382_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01452-2","volume":"15","author":"E Glavind","year":"2020","unstructured":"Glavind, E. et al. The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson\u2019s disease. Orphanet J. Rare Dis. 15, 173 (2020).","journal-title":"Orphanet J. Rare Dis."},{"key":"57382_CR33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/hep.20803","volume":"42","author":"TY Tsui","year":"2005","unstructured":"Tsui, T. Y. et al. rAAV-mediated stable expression of heme oxygenase-1 in stellate cells: a new approach to attenuate liver fibrosis in rats. Hepatology 42, 335\u2013342 (2005).","journal-title":"Hepatology"},{"key":"57382_CR34","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.jhep.2020.12.010","volume":"74","author":"G Wei","year":"2021","unstructured":"Wei, G. et al. Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB\/c.Abcb4(-\/-) mouse model of PFIC3. J. Hepatol. 74, 1416\u20131428 (2021).","journal-title":"J. Hepatol."},{"key":"57382_CR35","unstructured":"Schilsky, M. L. & Mistry, P. K. Chapter 42 - Wilson disease and the kidney. In Genetic Diseases of the Kidney (eds Lifton, R. P., Somlo, S., Giebisch, G. H. & Seldin D. W.) (Academic Press, 2009)."},{"key":"57382_CR36","doi-asserted-by":"publisher","first-page":"e38327","DOI":"10.1371\/journal.pone.0038327","volume":"7","author":"LW Gray","year":"2012","unstructured":"Gray, L. W. et al. Urinary copper elevation in a mouse model of Wilson\u2019s disease is a regulated process to specifically decrease the hepatic copper load. PLoS ONE 7, e38327 (2012).","journal-title":"PLoS ONE"},{"key":"57382_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-017-1214-8","volume":"15","author":"L Li","year":"2017","unstructured":"Li, L. et al. The spleen in liver cirrhosis: revisiting an old enemy with novel targets. J. Transl. Med. 15, 111 (2017).","journal-title":"J. Transl. Med."},{"key":"57382_CR38","doi-asserted-by":"publisher","first-page":"100844","DOI":"10.1016\/j.jhepr.2023.100844","volume":"5","author":"E Gonzales","year":"2023","unstructured":"Gonzales, E. et al. Outcomes of 38 patients with PFIC3: impact of genotype and of response to ursodeoxycholic acid therapy. JHEP Rep. 5, 100844 (2023).","journal-title":"JHEP Rep."},{"key":"57382_CR39","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/hep4.1149","volume":"2","author":"SB Schatz","year":"2018","unstructured":"Schatz, S. B. et al. Phenotypic spectrum and diagnostic pitfalls of ABCB4 deficiency depending on age of onset. Hepatol. Commun. 2, 504\u2013514 (2018).","journal-title":"Hepatol. Commun."},{"key":"57382_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ajpath.2014.10.013","volume":"185","author":"N Ikenaga","year":"2015","unstructured":"Ikenaga, N. et al. A new Mdr2(-\/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer. Am. J. Pathol. 185, 325\u2013334 (2015).","journal-title":"Am. J. Pathol."},{"key":"57382_CR41","doi-asserted-by":"publisher","first-page":"113197","DOI":"10.1016\/j.biopha.2022.113197","volume":"152","author":"WI Ho","year":"2022","unstructured":"Ho, W. I. et al. Liposome-encapsulated curcumin attenuates HMGB1-mediated hepatic inflammation and fibrosis in a murine model of Wilson\u2019s disease. Biomed. Pharmacother. 152, 113197 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"57382_CR42","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1172\/JCI37607","volume":"119","author":"J Zhu","year":"2009","unstructured":"Zhu, J., Huang, X. & Yang, Y. The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice. J. Clin. Investig. 119, 2388\u20132398 (2009).","journal-title":"J. Clin. Investig."},{"key":"57382_CR43","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1182\/blood-2010-10-314518","volume":"117","author":"AT Martino","year":"2011","unstructured":"Martino, A. T. et al. The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9\u2013dependent innate immune responses in the liver. Blood 117, 6459\u20136468 (2011).","journal-title":"Blood"},{"key":"57382_CR44","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/hep.24625","volume":"55","author":"M H\u00f6sel","year":"2012","unstructured":"H\u00f6sel, M. et al. Toll-like receptor 2\u2013mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors. Hepatology 55, 287\u2013297 (2012).","journal-title":"Hepatology"},{"key":"57382_CR45","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1182\/blood-2016-11-751040","volume":"129","author":"GL Rogers","year":"2017","unstructured":"Rogers, G. L. et al. Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8+ T cells. Blood 129, 3184\u20133195 (2017).","journal-title":"Blood"},{"key":"57382_CR46","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1172\/JCI122372","volume":"128","author":"K Kuranda","year":"2018","unstructured":"Kuranda, K. et al. Exposure to wild-type AAV drives distinct capsid immunity profiles in humans. J. Clin. Investig. 128, 5267\u20135279 (2018).","journal-title":"J. Clin. Investig."},{"key":"57382_CR47","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1016\/j.ymthe.2023.10.015","volume":"31","author":"D Duan","year":"2023","unstructured":"Duan, D. Lethal immunotoxicity in high-dose systemic AAV therapy. Mol. Ther. 31, 3123\u20133126 (2023).","journal-title":"Mol. Ther."},{"key":"57382_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/713754","volume":"2014","author":"M Scorza","year":"2014","unstructured":"Scorza, M. et al. Genetic diseases that predispose to early liver cirrhosis. Int. J. Hepatol. 2014, 713754 (2014).","journal-title":"Int. J. Hepatol."},{"key":"57382_CR49","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1093\/hmg\/8.9.1665","volume":"8","author":"OI Buiakova","year":"1999","unstructured":"Buiakova, O. I. et al. Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation. Hum. Mol. Genet. 8, 1665\u20131671 (1999).","journal-title":"Hum. Mol. Genet."},{"key":"57382_CR50","doi-asserted-by":"publisher","first-page":"e12551","DOI":"10.1097\/MD.0000000000012551","volume":"97","author":"C Qvigstad","year":"2018","unstructured":"Qvigstad, C. et al. The elevated prevalence of risk factors for chronic liver disease among ageing people with hemophilia and implications for treatment. Medicine 97, e12551 (2018).","journal-title":"Medicine"},{"key":"57382_CR51","doi-asserted-by":"publisher","first-page":"107602962211282","DOI":"10.1177\/10760296221128294","volume":"28","author":"MC Shen","year":"2022","unstructured":"Shen, M. C. et al. Prevalence of non-alcoholic fatty liver disease and associated factors in patients with moderate or severe hemophilia: a multicenter-based study. Clin. Appl. Thromb. Hemost. 28, 10760296221128294 (2022).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"57382_CR52","doi-asserted-by":"crossref","unstructured":"Pekrun, K. et al. Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectors. JCI Insight 4, e131610 (2019).","DOI":"10.1172\/jci.insight.131610"},{"key":"57382_CR53","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.omtm.2021.04.010","volume":"21","author":"M Cabanes-Creus","year":"2021","unstructured":"Cabanes-Creus, M. et al. Single amino acid insertion allows functional transduction of murine hepatocytes with human liver tropic AAV capsids. Mol. Ther. Methods Clin. Dev. 21, 607\u2013620 (2021).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"57382_CR54","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/gt.2012.67","volume":"20","author":"AP Dane","year":"2013","unstructured":"Dane, A. P., Wowro, S. J., Cunningham, S. C. & Alexander, I. E. Comparison of gene transfer to the murine liver following intraperitoneal and intraportal delivery of hepatotropic AAV pseudo-serotypes. Gene Ther. 20, 460\u2013464 (2013).","journal-title":"Gene Ther."},{"key":"57382_CR55","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1089\/hum.2017.220","volume":"29","author":"A Maddalena","year":"2018","unstructured":"Maddalena, A. et al. High-throughput screening identifies kinase inhibitors that increase dual adeno-associated viral vector transduction in vitro and in mouse retina. Hum. Gene Ther. 29, 886\u2013901 (2018).","journal-title":"Hum. Gene Ther."},{"key":"57382_CR56","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nprot.2015.017","volume":"10","author":"I Mederacke","year":"2015","unstructured":"Mederacke, I., Dapito, D. H., Aff\u00f2, S., Uchinami, H. & Schwabe, R. F. High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers. Nat. Protoc. 10, 305\u2013315 (2015).","journal-title":"Nat. Protoc."},{"key":"57382_CR57","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nprot.2011.301","volume":"6","author":"IF Khan","year":"2011","unstructured":"Khan, I. F., Hirata, R. K. & Russell, D. W. AAV-mediated gene targeting methods for human cells. Nat. Protoc. 6, 482\u2013501 (2011).","journal-title":"Nat. Protoc."},{"key":"57382_CR58","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.omtm.2021.11.011","volume":"24","author":"M Cabanes-Creus","year":"2022","unstructured":"Cabanes-Creus, M. et al. Novel human liver-tropic AAV variants define transferable domains that markedly enhance the human tropism of AAV7 and AAV8. Mol. Ther. Methods Clin. Dev. 24, 88\u2013101 (2022).","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57382-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57382-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57382-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T15:07:13Z","timestamp":1743001633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57382-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57382"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57382-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"4 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.F., N.B.P., and P.P. are inventors in patent n. WO2022184650 -Use of microRNAs in the treatment of fibrosis. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2118"}}